After a thorough and comprehensive review of proposals received from suppliers of viral marker testing platforms and assays, CTS has decided to convert to the Ortho VERSEIA Integrated Processor (VIP) viral marker testing platform and associated assays in January 2021. An exact conversion date will be provided when available. We are confident that the VERSIA system will allow us to continue delivering on our commitment to support our clients in their life-saving mission.
Read all about it on the Communication page by clicking this link: Communications
On June 13, 2019, the new CTS Laboratory Information System was successfully implemented in Cha...
CTS was recently notified that one of the tubes listed in the Sample Acceptability document...
That’s just one of the reasons that National Blood Donor Month, which has taken place each Jan...
Celebrate National Blood Donor Month throughout January by inviting eligible individuals to donate b...
As the US coast prepares for Hurricane Florence to make landfall, we have received importan...
The CTS Medical Advisory Board recently agreed upon a revision to our standard testing algorithm thi...